Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.
Menillo
S A
SA
Goldberg
S L
SL
McKiernan
P
P
Pecora
A L
AL
D000328:Adult; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017053:Infection Control; D007948:Leukemia, Monocytic, Acute / Q000628:therapy; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019226:Oral Ulcer / Q000188:drug therapy* / Q000209:etiology; D011701:PUVA Therapy; D011241:Prednisone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D014184:Transplantation, Homologous / Q000009:adverse effects*; D014987:Xerostomia / Q000188:drug therapy / Q000209:etiology
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011241:Prednisone; D016559:Tacrolimus